Ghent University Academic Bibliography

Show Sort by

Your filters: cql: parent exact "RADIOTHERAPY AND ONCOLOGY"

Add to list
- Journal Article
- A1
- open access
Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients : evaluation of the added prognostic value for overall survival and locoregional recurrence

Janna E van Timmeren, Wouter van Elmpt, Ralph TH Leijenaar, Bart Reymen, René Monshouwer, Johan Bussink, Leen Paelinck (UGent) , Evelien Bogaert (UGent) , Carlos De Wagter (UGent) , ELHASEEN ELAMIN (UGent) , et al.

(2019) RADIOTHERAPY AND ONCOLOGY. 136. p.78-85
Add to list
- Journal Article
- A1
- open access
REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

Petra Seibold, Adam Webb, Miguel E. Aguado-Barrera, David Azria, Celine Bourgier, Muriel Brengues, Erik Briers, Renée Bultijnck (UGent) , Patricia Calvo-Crespo, Ana Carballo, et al.

(2019) Radiotherapy and Oncology. 138. p.59-67
Add to list
- Journal Article
Radiation Oncology. Optimal Health for All, Together. ESTRO vision, 2030

Yolande Lievens, Umberto Ricardi, Philip Poortmans, Dirk Verellen, Chiara Gasparotto, Christine Verfaillie and Alessandro J. Cortese

(2019) Radiotherapy and Oncology. p.86-97
Add to list
- Journal Article
- open access
National costs and resource requirements of external beam radiotherapy: A time-driven activity-based costing model from the ESTRO-HERO project

Noémie Defourny (UGent) , Lionel Perrier, Josep-Maria Borras, Mary Coffey, Julietta Corral, Sophie Hoozée (UGent) , Judith van Loon, Cai Grau and Yolande Lievens (UGent)

(2019) Radiotherapy and Oncology. p.187-194
Add to list
- Conference Paper
- C3
Patient-reported outcomes after stereotactic body radiotherapy in lung cancer: The Lung PLUS study

Lotte van der Weijst (UGent) , Renée Bultijnck (UGent) , Axel Van Damme, Marc Van Eijkeren (UGent) , Veerle Surmont (UGent) and Yolande Lievens (UGent)

(2019) RADIOTHERAPY AND ONCOLOGY. 133(suppl. 1). p.S103-S103
Add to list
- Conference Paper
- C3
Is locally advanced cervix adenocarcinoma less radiosensitive than squamous cell carcinoma?

Katrien Vandecasteele (UGent) , Emiel De Jaeghere (UGent) , Philippe Tummers (UGent) , Amin Makar (UGent) , Pieter De Visschere (UGent) , Koen Van de Vijver (UGent) , Eline Naert (UGent) and Hannelore Denys (UGent)

(2019) RADIOTHERAPY AND ONCOLOGY. 133(suppl. 1). p.S814-S815
Add to list
National costs and resource requirements of external beam radiotherapy : a time-driven activity-based costing model from the ESTRO-HERO project

Noémie Defourny (UGent) , Lionel Perrier, Josep-Maria Borras, Mary Coffey, Julietta Corral, Sophie Hoozée (UGent) , Judith van Loon, Cai Grau and Yolande Lievens (UGent)

(2019) RADIOTHERAPY AND ONCOLOGY. 138. p.187-194
Add to list
Critical review and quality-assessment of cost analyses in radiotherapy : how reliable are the data?

Noémie Defourny (UGent) , Christel Monten (UGent) , Cai Grau, Yolande Lievens (UGent) and Lionel Perrier

(2019) RADIOTHERAPY AND ONCOLOGY. 141. p.14-26
Add to list
Adjuvant breast radiotherapy : how to trade-off cost and effectiveness?

Christel Monten (UGent) and Yolande Lievens (UGent)

(2018) RADIOTHERAPY AND ONCOLOGY. 126(1). p.132-138
Add to list
Estimating the number of fractions by tumour site for European countries in 2012 and 2025 : an ESTRO-HERO analysis

Josep M Borras, Cai Grau, Julieta Corral, Karen Wong, Michael B Barton, Jacques Ferlay, Freddie Bray and Yolande Lievens (UGent)

(2018) RADIOTHERAPY AND ONCOLOGY. 126(2). p.198-204

Academic Bibliography

Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients : evaluation of the added prognostic value for overall survival and locoregional recurrence

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

Radiation Oncology. Optimal Health for All, Together. ESTRO vision, 2030

National costs and resource requirements of external beam radiotherapy: A time-driven activity-based costing model from the ESTRO-HERO project

Patient-reported outcomes after stereotactic body radiotherapy in lung cancer: The Lung PLUS study

Is locally advanced cervix adenocarcinoma less radiosensitive than squamous cell carcinoma?

National costs and resource requirements of external beam radiotherapy : a time-driven activity-based costing model from the ESTRO-HERO project

Critical review and quality-assessment of cost analyses in radiotherapy : how reliable are the data?

Adjuvant breast radiotherapy : how to trade-off cost and effectiveness?

Estimating the number of fractions by tumour site for European countries in 2012 and 2025 : an ESTRO-HERO analysis

Contents

Support

Contact